Tuesday, 7 May 2013

Mitsubishi Corporation Profile & SWOT Analysis: Pharmaceuticals, Healthcare and more Reviewed at RnRCompanyProfiles.com



Mitsubishi Corporation (Mitsubishi) is a diversified business group. Mitsubishi operates in several industries including energy, metals, chemicals, machinery, foods, industrial finance and environmental business, among others. Mitsubishi operates through more than 200 offices in about 90 countries. The group has operations in seven regions, namely, Japan, North America, Latin America, Europe, Commonwealth of Independent States (CIS), Middle East and Africa, and Asia and Oceania. Mitsubishi is headquartered in Tokyo, Japan.

The group intends to enhance earning margins and build sustainable corporate value.
Mar 22, 2013: Modec, Mistui, MOL And Marubeni To Participate In Ultra-deepwater FPSO Chartering Project
Mar 19, 2013: Buru Energy Provides Operations Update
Mar 19, 2013: JAPEX Provides Update On Oil Production From Terang Gas Field At Kangean PSC Area In East Java, Indonesia
Mar 14, 2013: Buru Energy Provides Update On Yulleroo-4 Well In EP 436, Australia
Mar 07, 2013: Buru Energy Provides Update On Yulleroo-4 Well In EP 436, AustraliaGDGE353FSA

This comprehensive SWOT profile of Mitsubishi Corporation provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Mitsubishi Pharma Europe Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile: http://www.rnrcompanyprofiles.com/mitsubishi-pharma-europe-ltd-pharmaceuticals-healthcare-deals-and-alliances-profile-report.html
Mitsubishi Pharma Europe Ltd (Mitsubishi Pharma) is a pharmaceutical and health care service provider, based in the UK. The company conducts trials in Europe in the following therapy areas; cardiovascular, diabetes, CNS and renal conditions. The staff include regulatory, QA, clinical, biostatistics, medical information, pharmacovigilance, pharmaceutical technology and marketing. Its product Argatroban, a synthetic direct thrombin inhibitor is indicated for anticoagulation in adult patients with heparin-induced thrombocytopenia type II (HIT type II). It operates in UK, Germany, Belgium, France, Japan, US of America, Korea, China, Taiwan, and Indonesia. Mitsubishi Pharma is headquartered in London, UK.

Mitsubishi Pharma Europe Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

Scope:
- Financial Deals
- Deals by Year
- Deals by Type
- Deals by Region
- Deals by Sub-sector
- Major Deals
- Key Employees
- Important Locations and Subsidiaries
- Key Competitors
- Key Recent Developments


Mitsubishi Tanabe Pharma Corporation – SWOT, Strategy and Corporate Finance Report - is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360? View of the company.
- Detailed information on Mitsubishi Tanabe Pharma Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Mitsubishi Tanabe Pharma Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Mitsubishi Tanabe Pharma Corporation including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Mitsubishi Tanabe Pharma Corporation
- Intelligence on Mitsubishi Tanabe Pharma Corporationnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Mitsubishi Tanabe Pharma Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends


About:
RnRCompanyProfiles.com is your single source for all competitive intelligence data, reports on company profiles and SWOT analysis of business organizations.